A-A-0051789(DM)
23 December 1986
INTERIM COMMERCIAL ITEM DESCRIPTION
GLIPIZIDE TABLETS
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical Material, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Salient characteristics:
Shall be Glipzide Tablets.
All ingredients in the tablets shall be of Pharmaceutical grade.
For Strength 1, Size 1 and Size 2, shall contain 5 mg of Glipizide per tablet within the applicable assay limits for the tablets.
For Strength 2, shall contain 10 mg of Glipizide per tablet within the applicable assay limits for the tablets.
Workmanship. The tablets shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Bottle (BT).]
For Strength 1, Size 1 and Strength 2, one bottle containing 100 tablets, as specified, constitutes one unit.
For Strength 2, Size 2, one bottle containing 500 tablets, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires call Parts Hangar, Inc (727) 493-0744
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business